CardioGenics Holdings Inc
CGNH
$0.0001
$0.000.00%
| 01/31/2016 | 10/31/2015 | 07/31/2015 | 04/30/2015 | 01/31/2015 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.52% | 269.09% | -56.77% | -14.51% | -22.42% |
| Depreciation & Amortization | -18.18% | -56.41% | -37.78% | -4.55% | -2.22% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.24% | 1.04% | -49.42% | -24.63% | -21.55% |
| Operating Income | 2.24% | -1.04% | 49.42% | 24.63% | 21.55% |
| Income Before Tax | 88.19% | 73.13% | -8.12% | 136.23% | -159.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 88.19% | 73.13% | -8.12% | 136.23% | -159.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 88.19% | 73.13% | -8.12% | 136.23% | -159.75% |
| EBIT | 2.24% | -1.04% | 49.42% | 24.63% | 21.55% |
| EBITDA | 1.89% | -2.56% | 49.69% | 25.07% | 21.89% |
| EPS Basic | 92.31% | 85.02% | 33.33% | 125.00% | -107.25% |
| Normalized Basic EPS | 92.13% | 84.50% | 32.76% | 125.71% | -106.98% |
| EPS Diluted | 92.31% | 85.02% | 0.00% | 112.00% | -43.00% |
| Normalized Diluted EPS | 92.13% | 84.50% | 32.76% | 122.86% | -106.98% |
| Average Basic Shares Outstanding | 57.52% | 76.79% | 61.85% | 45.48% | 24.74% |
| Average Diluted Shares Outstanding | 57.52% | 76.79% | 61.85% | 68.97% | 24.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
